FindTrial
Sign In

Study for the predictive value of FDP combined with ESR and CRP in the diagnosis of periprosthetic infection

Study for the predictive value of FDP combined with ESR and CRP in the diagnosis of periprosthetic infection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020185
Enrollment
Unknown
Registered
2018-12-19
Start date
2018-12-20
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip and knee joint disease

Interventions

Gold Standard:Immunohistochemistry and culture
Index test:FDP
&#32
D-dimer
CRP
IL-6
ESR

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) patients undergoing total hip and knee arthroplasty in our department since 2013; (2) patients with complete relevant indicators.

Exclusion criteria

Exclusion criteria: (1) patients diagnosed with rheumatoid arthritis and ankylosing spondylitis at the first THA and TKA; (2) surgical treatment for periprosthetic fractures and dislocation; (3) patients with malignant tumors in other parts of the body may affect the results.

Design outcomes

Primary

MeasureTime frame
FDP;D-dimer;CRP;IL-6;ESR;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactFuxing Pei

West China Hospital, Sichuan University

peifuxingvip@yeah.net+86 13208193509

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026